Argenx (ARGX) is a publicly traded Healthcare sector company. As of July 5, 2026, ARGX trades at $939.68 with a market cap of $58.44B and a P/E ratio of 0.00. ARGX moved +3.34% today. Year to date, ARGX is +12.15%; over the trailing twelve months it is +72.38%. Its 52-week range spans $510.06 to $953.58. Analyst consensus is strong buy with an average price target of $1,067.73. Rallies surfaces ARGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for ARGX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $939.68 |
| Market Cap | $58.44B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $953.58 |
| 52-Week Low | $510.06 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
18 analysts cover ARGX: 0 strong buy, 17 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1,067.73.